Evidence map›Paper›PMID 29137345›Full record

ReviewOncotarget2017

The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisy: a systematic review and meta-analysis.

Shuanshuan Xie, Lin Lu, Ming Li, Mengting Xiong, Shunping Zhou, Guoliang Zhang, Aimei Peng, Changhui Wang

Open access · diamondAbstract readReview
In one paragraph

Review in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Shuanshuan XieDepartment of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Lin LuDepartment of Nephrology, North Huashan Hospital, Fudan University, Shanghai, China.
Ming LiDepartment of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Mengting XiongDepartment of Cardiology Medicine, Pudong Hospital, Fudan University, Shanghai, China.
Shunping ZhouDepartment of Cardiology Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China.
Guoliang ZhangDepartment of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Aimei PengDepartment of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Changhui WangDepartment of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Tongji University · CNShanghai Tenth People's Hospital · CNFudan University · CNHuashan Hospital · CNYangpu Hospital of Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the efficacy and safety of adjunctive corticosteroids in the treatment of patients with tuberculous pleurisy.

methodsThe PubMed, Cochrane, Medline, Embase, Web of Science and Chinese National Knowledge Infrastructure were searched. Clinical trials of corticosteroids compared with control were eligible for inclusion.

resultsTen studies (6 randomized controlled trials [RCTs] and 4 non-RCTs) with 957 participants met the inclusion criteria. Compared to the controls (placebos or non-steroids), adjunctive corticosteroid use reduced the risk of residual pleural fluid after 4 weeks and the number of days to symptom improvement; however, there was no convincing evidence to support the positive effects of corticosteroids over the long term (8 weeks) on residual pleural fluid, pleural thickening, or pleural adhesions, and there was no statistical difference between the corticosteroid group and control group with respect to 7-days relief of the clinical symptoms or death from any cause. In addition, more adverse events were observed in patients who received corticosteroids than in those in the control group.

conclusionsOur results suggest that adjunctive corticosteroid use did not improve long-term efficacy and might induce more adverse events, although the risk of residual pleural fluid at 4 weeks and the number of days to symptom improvement were reduced.

Indexed as

corticosteroidpleural adhesionpleural fluidpleural thickeningtuberculous pleurisy

Identifiers

PMID29137345
PMCPMC5669971
OpenAlexW2616916226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.